Stock Events

Stock Events

Ginkgo Bioworks 

$0.000400
566
+$0.00+0% Thursday 17:07

Statistics

Day High
0.0149
Day Low
0.0149
52W High
0.0149
52W Low
0.0004
Volume
1,000
Avg. Volume
-
Mkt Cap
26,936.11
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-2
-1.58
-1.17
-0.75
Expected EPS
-1.16
Actual EPS
N/A

Financials

-183.81%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
170.16MRevenue
-312.76MNet Income

Analyst Ratings

7.00Average Price Target
The highest estimate is 9.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
50%
Sell
50%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DNABW. It's not an investment recommendation.
Tesla
88
TSLA
Palantir Technologies
84
PLTR
NVIDIA
81
NVDA
Apple
77
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Twist Bioscience
TWST
Mkt Cap7.44B
Twist Bioscience Corporation operates in the synthetic biology field, offering DNA synthesis products that compete with Ginkgo Bioworks' platform for programming cells.
Synlogic
SYBX
Mkt Cap8.32M
Synlogic, Inc. is engaged in the development of therapeutics that leverage synthetic biology, competing in the biotech space where Ginkgo Bioworks also operates.
Codexis
CDXS
Mkt Cap170.83M
Codexis, Inc. specializes in protein engineering and enzyme optimization, competing with Ginkgo Bioworks in the field of bio-catalysis and bio-manufacturing.
Evogene
EVGN
Mkt Cap9.49M
Evogene Ltd. applies computational biology and synthetic biology to develop products in agriculture, competing with Ginkgo Bioworks in the agri-biotech sector.
Pacific Biosciences of California
PACB
Mkt Cap357.46M
Pacific Biosciences of California, Inc. provides sequencing systems that compete with Ginkgo Bioworks' offerings in the genomics and genetic engineering space.
Illumina
ILMN
Mkt Cap28.82B
Illumina, Inc. is a leader in genomics and DNA sequencing technologies, indirectly competing with Ginkgo Bioworks by enabling synthetic biology research and applications.
CRISPR Therapeutics
CRSP
Mkt Cap5.18B
CRISPR Therapeutics AG focuses on gene editing technologies, competing in the broader biotech space for genetic engineering applications, overlapping with Ginkgo's market.
Editas Medicine
EDIT
Mkt Cap433.1M
Editas Medicine, Inc. is involved in gene editing, competing in the genetic modification space, which is relevant to Ginkgo Bioworks' synthetic biology applications.

About

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Show more...
CEO
Jason Kelly
Employees
485
Country
United States
ISIN
US37611X1182

Listings

XNYS
US
DNA
MX
MX
DNA.MX
BOATS
BOATS
DNA.BOATS
OTC Link
US
DNABW

0 Comments

Share your thoughts

FAQ

What is Ginkgo Bioworks stock price today?▼
The current price of DNABW is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Ginkgo Bioworks stock price performance more closely on the chart.
What is Ginkgo Bioworks stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Ginkgo Bioworks stocks are traded under the ticker DNABW.
What is Ginkgo Bioworks market cap?▼
Today Ginkgo Bioworks has the market capitalization of 26,936.11
When is the next Ginkgo Bioworks earnings date?▼
Ginkgo Bioworks is going to release the next earnings report on November 16, 2026.
What were Ginkgo Bioworks earnings last quarter?▼
DNABW earnings for the last quarter are -0.75 USD per share, whereas the estimation was -0.9 USD resulting in a +16.2% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ginkgo Bioworks revenue for the last year?▼
Ginkgo Bioworks revenue for the last year amounts to 170.16M USD.
What is Ginkgo Bioworks net income for the last year?▼
DNABW net income for the last year is -312.76M USD.
How many employees does Ginkgo Bioworks have?▼
As of August 23, 2026, the company has 485 employees.
In which sector is Ginkgo Bioworks located?▼
Ginkgo Bioworks operates in the Health & Wellness sector.
When did Ginkgo Bioworks complete a stock split?▼
The last stock split for Ginkgo Bioworks was on August 20, 2024 with a ratio of 1:40.
Where is Ginkgo Bioworks headquartered?▼
Ginkgo Bioworks is headquartered in BOSTON, United States.